at 001

Anti-VEGFR2/KDR/CD309 Antibody (AT001) is a human antibody expressed in CHO cells, specifically targeting VEGFR2/KDR/CD309. It features a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. For an isotype control, refer to HumanIgG4kappa, Isotype Control.

TNM001 is an anti-RSV fully humanized monoclonal antibody for the study of lower respiratory tract disease due to RSV infection.

PTA001_A4 (Anti-CDH17/Cadherin-17 Antibody) is a humanized antibody targeting CDH17/Cadherin-17 with potential anti-tumor activity, inhibits the growth of tumor cells, and can be used for cancer research.

NMC-001 is a human IgG1 monoclonal antibody (mAb) that targets MDM2. It is useful for pancreatic cancer research. The recommended isotype control is HumanIgG1kappa, Isotype Control.

PNT001 is a human IgG1 monoclonal antibody (mAb) targeting cis-pT231 Tau. It is applicable for research in neurodegenerative diseases and traumatic brain injury (TBI). The recommended isotype control is Human IgG1 kappa, Isotype Control.

STT-001 is a human monoclonal antibody (mAb) that targets B7-H1/PD-L1/CD274. It is utilized for research on solid tumors.

VDJ001 is a high-affinity humanized anti-IL-6R monoclonal antibody. It is applicable for research in rheumatoid arthritis.

SG-001 is a human monoclonal antibody (mAb) that targets PDCD1/PD-1/CD279. It is applicable for research on cervical cancer, colorectal cancer, solid tumors, and biliary tract cancer.

AK-001 is a human-derived IgG1 antibody targeting Siglec-8. VRC-01 is applicable for studies on chronic rhinosinusitis with nasal polyps. For the isotype control of AK-001, refer to HumanIgG1kappa (Isotype Control).